Shenggu Tongchuang

Beijing Shenggu Tongchuang Technology Development Co., Ltd. is a company dedicated to developing personalized genetic testing for disease prediction and treatment. The company leverages a technology platform integrating revolutionary semiconductor gene sequencing, efficient data analysis, and clinical applications to provide emerging services for disease prediction, early warning, prevention, and personalized medicine.
Currently, Shenggu Tongchuang has a core team composed of interdisciplinary talents in gene sequencing, information analysis, and software development, and has established a database for applying gene sequencing data to clinical practice as well as advanced integrated technologies for sequencing, data analysis, and clinical applications, which can be used for efficient and reliable detection of cancer gene mutations and guidance of tumor-targeted drug therapy. In addition, Shenggu Tongchuang has undertaken the National "863" Program project — "Translational Medicine Bioinformatics Information Technology and Product Development".
The company has modern business management concepts and a young, united team for R&D, production, sales, and investment operations. Adhering to the principles of people-orientedness, integrity and pragmatism, scientific and technological progress, quality first, and benefiting people's health, the company is willing to join hands with colleagues and people of aspiration to make greater contributions to the revitalization of personalized medicine in China and scientific progress!
:*